160 related articles for article (PubMed ID: 12878509)
21. Grepafloxacin against penicillin-resistant pneumococci in the rabbit meningitis model.
Gerber CM; Tovar L; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
J Antimicrob Chemother; 2000 Aug; 46(2):249-53. PubMed ID: 10933648
[TBL] [Abstract][Full Text] [Related]
22. In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point.
Alkorta M; Giménez MJ; Vicente D; Aguilar L; Pérez-Trallero E
Int J Antimicrob Agents; 2005 Feb; 25(2):163-7. PubMed ID: 15664487
[TBL] [Abstract][Full Text] [Related]
23. Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agents.
Browne FA; Bozdogan B; Clark C; Kelly LM; Ednie L; Kosowska K; Dewasse B; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2003 Dec; 47(12):3815-24. PubMed ID: 14638489
[TBL] [Abstract][Full Text] [Related]
24. Bactericidal activity of levofloxacin against Streptococcus pneumoniae in an in-vitro model simulating serum pharmacokinetic parameters.
Shah PM; Schwärzel R
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():71-5. PubMed ID: 10404342
[TBL] [Abstract][Full Text] [Related]
25. Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin.
Browne FA; Clark C; Bozdogan B; Dewasse BE; Jacobs MR; Appelbaum PC
Int J Antimicrob Agents; 2002 Aug; 20(2):93-9. PubMed ID: 12297357
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of single mutations in topoisomerase type II genes among levofloxacin-susceptible clinical strains of Streptococcus pneumoniae isolated in the United States in 1992 to 1996 and 1999 to 2000.
Davies TA; Evangelista A; Pfleger S; Bush K; Sahm DF; Goldschmidt R
Antimicrob Agents Chemother; 2002 Jan; 46(1):119-24. PubMed ID: 11751121
[TBL] [Abstract][Full Text] [Related]
27. In vitro pharmacodynamics of moxifloxacin versus levofloxacin against 4 strains of Streptococcus pneumoniae: 1 wild type, 2 first-step parC mutants, and 1 pump mutant.
Schafer J; Hovde LB; Simonson D; Rotschafer JC
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):155-61. PubMed ID: 17910998
[TBL] [Abstract][Full Text] [Related]
28. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
Stratton CW; Aldridge KE; Gelfand MS
Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
[TBL] [Abstract][Full Text] [Related]
29. Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
Rodoni D; Hänni F; Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
Antimicrob Agents Chemother; 1999 Apr; 43(4):963-5. PubMed ID: 10103211
[TBL] [Abstract][Full Text] [Related]
30. Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia.
Endimiani A; Brigante G; Bettaccini AA; Luzzaro F; Grossi P; Toniolo AQ
BMC Infect Dis; 2005 Nov; 5():106. PubMed ID: 16307682
[TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime.
Friedland IR; Klugman KP
Antimicrob Agents Chemother; 1997 Sep; 41(9):1888-91. PubMed ID: 9303379
[TBL] [Abstract][Full Text] [Related]
32. Genetic analyses of mutations contributing to fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae.
Weigel LM; Anderson GJ; Facklam RR; Tenover FC
Antimicrob Agents Chemother; 2001 Dec; 45(12):3517-23. PubMed ID: 11709333
[TBL] [Abstract][Full Text] [Related]
33. New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits.
Täuber MG; Hackbarth CJ; Scott KG; Rusnak MG; Sande MA
Antimicrob Agents Chemother; 1985 Mar; 27(3):340-2. PubMed ID: 3838872
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
Tan TQ; Schutze GE; Mason EO; Kaplan SL
Antimicrob Agents Chemother; 1994 May; 38(5):918-23. PubMed ID: 8067771
[TBL] [Abstract][Full Text] [Related]
35. Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000.
Critchley IA; Blosser-Middleton RS; Jones ME; Karlowsky JA; Karginova EA; Thornsberry C; Sahm DF
Int J Antimicrob Agents; 2002 Aug; 20(2):100-7. PubMed ID: 12297358
[TBL] [Abstract][Full Text] [Related]
36. Comparison of drug sensitivity and genotypes of clinically isolated strains of levofloxacin-resistant Streptococcus pneumoniae obtained from Okinawa Island, the Japanese main island and Hong Kong.
Sunagawa S; Fujita J; Higa F; Tateyama M; Haranaga S; Nakasone I; Yamane N; Uno T
J Antibiot (Tokyo); 2011 Aug; 64(8):539-45. PubMed ID: 21587266
[TBL] [Abstract][Full Text] [Related]
37. In vitro susceptibility of penicillin-resistant Streptococcus pneumoniae to levofloxacin, selection of resistant mutants, and time-kill synergy studies of levofloxacin combined with vancomycin, teicoplanin, fusidic acid, and rifampin.
Klugman KP; Capper T; Bryskier A
Antimicrob Agents Chemother; 1996 Dec; 40(12):2802-4. PubMed ID: 9124844
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro.
Perrig M; Acosta F; Cottagnoud M; Gerber CM; Täuber MG; Cottagnoud P
J Antimicrob Chemother; 2001 May; 47(5):701-4. PubMed ID: 11328789
[TBL] [Abstract][Full Text] [Related]
39. Fluoroquinolone resistance in Streptococcus pneumoniae isolates in Germany from 2004-2005 to 2014-2015.
Schmitz J; van der Linden M; Al-Lahham A; Levina N; Pletz MW; Imöhl M
Int J Med Microbiol; 2017 Jun; 307(4-5):216-222. PubMed ID: 28506425
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Visalli MA; Jacobs MR; Appelbaum PC
Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
